Relationship and clinical significance between matrix metalloproteinase-9, vascular endothelial growth factor and pathologic type and TNM stage of lung cancer

CLINICAL FOCUS ›› 2010, Vol. 25 ›› Issue (8): 658-660.

Previous Articles Next Articles

Relationship and clinical significance between matrix metalloproteinase-9, vascular endothelial growth factor and pathologic type and TNM stage of lung cancer

BAO Xiao-ling;JIANG Xiu-juan

Online:2010-04-20 Published:2010-04-20

Abstract

CLC Number:

R734.2

BAO Xiao-ling;JIANG Xiu-juan. Relationship and clinical significance between matrix metalloproteinase-9, vascular endothelial growth factor and pathologic type and TNM stage of lung cancer[J]. CLINICAL FOCUS, 2010, 25(8): 658-660.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2010/V25/I8/658

[1]	Li Shufan, Wang Yuxiu, Jiang Zhenghua. The correlation between the prognosis of lung adenocarcinoma with acquired resistance to the first-generation EGFR TKI and the T790M mutation [J]. Clinical Focus, 2022, 37(11): 985-991.
[2]	Huang Ping, Liu Hanyun, Li Yuhong. Risk factors of lung cancer with pulmonary embolism:a meta-analysis [J]. Clinical Focus, 2021, 36(12): 1061-1066.
[3]	. [J]. Clinical Focus, 2021, 36(12): 1132-1135.
[4]	Li Guanzhu, Lai Yuan, Zheng Xiaozhuo, Jiang Ran, Wei Ke. Effects of goal-directed fluid therapy on intraoperative balance between oxygen delivery and consumption and postoperative outcomes in thoracic surgery patients: a meta-analysis [J]. Clinical Focus, 2021, 36(8): 677-684.
[5]	Xu Ying, Han Caijuan, Fan Hong, Meng Zerong, Wang Xiaojun, Liu Hua. Relationship between long non-coding RNA overexpression and poor prognostic of small cell lung cancer: a meta-analysis [J]. Clinical Focus, 2021, 36(8): 685-690.
[6]	Wang Ai. Effects of Kangai injection combined with bevacizumab and DP scheme on efficacy and serum tumor markers and prognosis of NSCLC [J]. Clinical Focus, 2021, 36(6): 517-521.
[7]	Yang Ke, Chen Jun. Value of serum NSE, CEA and CA125 levels in diagnosis and efficacy evaluation of patients with small cell lung cancer [J]. Clinical Focus, 2021, 36(3): 225-228.
[8]	Liu Xinyan,Wei Hongyan, Dai Xianli, Liu Ying. Clinical efficacy of chemotherapy combined with location intervened by bronchoscope in central lung cancer [J]. Clinical Focus, 2016, 31(4): 389-391.
[9]	Li Yajie;Chen Kai. Analysis of transbronchial needle aspiration in 224 cases with mediastinal lymphadenectasis [J]. Clinical Focus, 2015, 30(10): 1159-1162.
[10]	. @@ [J]. Clinical Focus, 2015, 30(10): 1197-1200.
[11]	Chi Hongwei;Wang Canghai;Yang Zhiming;Ren Jinjun;Xu Qian;Chen Yanfang. Appilcation of apparent diffusion coefficient value in chemotherapy efficacy evaluation on non-small cell lung carcinoma [J]. Clinical Focus, 2015, 30(8): 883-887.
[12]	Du Junhua;Yin Yifa;Qiao Hongyuan. Effect of maintenance therapy with Huisheng Oral Liquid for patients in mid-advanced non-small cell lung cancer [J]. Clinical Focus, 2015, 30(6): 641-644.
[13]	Hu Shanshan;Zhang Shun;Cai Ting. Immunochemotherapy for advanced non-small cell lung cancer:a meta-analysis [J]. Clinical Focus, 2015, 30(3): 283-289.
[14]	Li Long;Tang Fabing;Yu Qin. Expression of EGFR and RAS/MAPK signal pathway-related proteins and their significance in lung adenocarcinoma [J]. Clinical Focus, 2015, 30(3): 290-292296.
[15]	Chen Yunping;Li Jiancheng;Zhang Jiangling;Hong Chaoxin;Luo Danfeng;Lai Zhangchao. Clinical effect of intensity modulated radiation therapy for treatment of local medium and advanced non-small cell lung cancer [J]. Clinical Focus, 2015, 30(1): 48-5051.

Relationship and clinical significance between matrix metalloproteinase-9, vascular endothelial growth factor and pathologic type and TNM stage of lung cancer

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments